Pablo Olivera (@poliverasendra) 's Twitter Profile
Pablo Olivera

@poliverasendra

Advanced IBD Fellow @SinaiHealth
ClinEpi MSc candidate @ihpmeuoft
Former GI @CemicEii
#IBD #ulcerativecolitis #Crohnsdisease

ID: 4396117337

linkhttps://www.linkedin.com/in/pablo-olivera-sendra-699866127/ calendar_today06-12-2015 17:29:20

644 Tweet

560 Followers

827 Following

Victoria Villarruel (@vickyvillarruel) 's Twitter Profile Photo

A 1 año del horror seguimos reclamando la libertad de nuestros compatriotas y de todos los rehenes que siguen secuestrados por Hamas, Shiri Silberman junto a sus dos hijos, Kfir y Ariel, a los hermanos Iair y Eitan Horn, a David y Ariel Cunio. Al terrorismo que destruye familias,

A 1 año del horror seguimos reclamando la libertad de nuestros compatriotas y de todos los rehenes que siguen secuestrados por Hamas, Shiri Silberman junto a sus dos hijos, Kfir y Ariel, a los hermanos Iair y Eitan Horn, a David y Ariel Cunio. Al terrorismo que destruye familias,
Israel ישראל (@israel) 's Twitter Profile Photo

Argentina 🇮🇱💙🇦🇷 We will never forget your kindness. We will never forget your solidarity. We will never forget your humanity. You give us hope. Gracias 🫶

liv (@livlayne_) 's Twitter Profile Photo

To my Jewish friends, I know it’s not much, but please know I wish I could hug you. Watching these videos has made me sick—and knowing how the world will likely respond makes it even worse. You’re in my heart.

Domingo Balderramo (@dcbalderramo) 's Twitter Profile Photo

Our recent publication describes real-life data on IBD treatment strategies in 7 hospitals from Argentina 🇦🇷 🔴 52% CD with colonic involvement 🔴 46% UC with extensive colitis 🟢 Biologics: CD 79% UC 34% 🟡 Surgery (3-yFU): CD 18% vs UC 1.4% pubmed.ncbi.nlm.nih.gov/39549817/

roypounder.apt (@apandt) 's Twitter Profile Photo

Read: "Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan" published at bit.ly/4969GkC #gitwitter #IBD #UC

Read: "Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan" published at bit.ly/4969GkC
#gitwitter #IBD #UC
Helmsley Charitable Trust (@helmsleytrust) 's Twitter Profile Photo

Innovative research is essential for enhancing our understanding of Crohn’s disease and advancing the development of future preventative therapies. Helmsley supported the Genetic, Environmental, Microbial (GEM) Project , which aimed to predict an individual’s risk of developing

Innovative research is essential for enhancing our understanding of Crohn’s disease and advancing the development of future preventative therapies. Helmsley supported the Genetic, Environmental, Microbial (GEM) Project , which aimed to predict an individual’s risk of developing